Cargando…

ANCA negative pauci-immune glomerulonephritis with systemic involvement

Systemic vasculitides (SV) are a group of diseases with multi system involvement and varied clinical presentation. Anti-neutrophil cytoplasmic antibody (ANCA) testing has high sensitivity and specificity for SV. We describe the clinical course of four patients who had pauci-immune glomerulonephritis...

Descripción completa

Detalles Bibliográficos
Autores principales: Sampathkumar, K., Ramakrishnan, M., Sah, A. K., Gowtham, S., Ajeshkumar, R. N.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878411/
https://www.ncbi.nlm.nih.gov/pubmed/20535271
http://dx.doi.org/10.4103/0971-4065.62096
_version_ 1782181863362658304
author Sampathkumar, K.
Ramakrishnan, M.
Sah, A. K.
Gowtham, S.
Ajeshkumar, R. N.
author_facet Sampathkumar, K.
Ramakrishnan, M.
Sah, A. K.
Gowtham, S.
Ajeshkumar, R. N.
author_sort Sampathkumar, K.
collection PubMed
description Systemic vasculitides (SV) are a group of diseases with multi system involvement and varied clinical presentation. Anti-neutrophil cytoplasmic antibody (ANCA) testing has high sensitivity and specificity for SV. We describe the clinical course of four patients who had pauci-immune glomerulonephritis with systemic involvement without serological ANCA positivity; they were followed up for a cumulative 55 patient months. The mean Birmingham vasculitis score score was 23. All four had systemic symptoms with arthralgias and fever (100%). Neurological manifestations were seen in two patients (66%). Accelerated hypertension was seen in one. One patient had pulmonary renal syndrome. Renal manifestation was characterized by nephrotic range of proteinuria with glomerular hematuria in all (100%) and severe renal failure requiring dialysis in three (66%). At admission the mean blood urea was 146 ± 19 mg% and mean serum creatinine was 5.6 ± 1.9 mg%. Renal biopsy revealed focal proliferative glomerulonephritis with crescents only in 20-30% of glomeruli. There was significant chronic interstitial involvement in two patients (66%). Therapy with pulse steroids, cyclophosphamide, and mycophenolate mofetil (MMF) was effective in three patients while one died with lung hemorrhage. In conclusion, majority of patients with ANCA negative pauci-immune glomerulonephritis have multi-system involvement at admission. Renal biopsy is characterized by focal proliferative lesions with crescents and significant chronic interstitial fibrosis. Immunosuppressive drugs in the form of corticosteroids, MMF and cyclophosphamide bring about marked renal recovery in most patients.
format Text
id pubmed-2878411
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-28784112010-06-09 ANCA negative pauci-immune glomerulonephritis with systemic involvement Sampathkumar, K. Ramakrishnan, M. Sah, A. K. Gowtham, S. Ajeshkumar, R. N. Indian J Nephrol Case Report Systemic vasculitides (SV) are a group of diseases with multi system involvement and varied clinical presentation. Anti-neutrophil cytoplasmic antibody (ANCA) testing has high sensitivity and specificity for SV. We describe the clinical course of four patients who had pauci-immune glomerulonephritis with systemic involvement without serological ANCA positivity; they were followed up for a cumulative 55 patient months. The mean Birmingham vasculitis score score was 23. All four had systemic symptoms with arthralgias and fever (100%). Neurological manifestations were seen in two patients (66%). Accelerated hypertension was seen in one. One patient had pulmonary renal syndrome. Renal manifestation was characterized by nephrotic range of proteinuria with glomerular hematuria in all (100%) and severe renal failure requiring dialysis in three (66%). At admission the mean blood urea was 146 ± 19 mg% and mean serum creatinine was 5.6 ± 1.9 mg%. Renal biopsy revealed focal proliferative glomerulonephritis with crescents only in 20-30% of glomeruli. There was significant chronic interstitial involvement in two patients (66%). Therapy with pulse steroids, cyclophosphamide, and mycophenolate mofetil (MMF) was effective in three patients while one died with lung hemorrhage. In conclusion, majority of patients with ANCA negative pauci-immune glomerulonephritis have multi-system involvement at admission. Renal biopsy is characterized by focal proliferative lesions with crescents and significant chronic interstitial fibrosis. Immunosuppressive drugs in the form of corticosteroids, MMF and cyclophosphamide bring about marked renal recovery in most patients. Medknow Publications 2010 /pmc/articles/PMC2878411/ /pubmed/20535271 http://dx.doi.org/10.4103/0971-4065.62096 Text en © Indian Journal of Nephrology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Sampathkumar, K.
Ramakrishnan, M.
Sah, A. K.
Gowtham, S.
Ajeshkumar, R. N.
ANCA negative pauci-immune glomerulonephritis with systemic involvement
title ANCA negative pauci-immune glomerulonephritis with systemic involvement
title_full ANCA negative pauci-immune glomerulonephritis with systemic involvement
title_fullStr ANCA negative pauci-immune glomerulonephritis with systemic involvement
title_full_unstemmed ANCA negative pauci-immune glomerulonephritis with systemic involvement
title_short ANCA negative pauci-immune glomerulonephritis with systemic involvement
title_sort anca negative pauci-immune glomerulonephritis with systemic involvement
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878411/
https://www.ncbi.nlm.nih.gov/pubmed/20535271
http://dx.doi.org/10.4103/0971-4065.62096
work_keys_str_mv AT sampathkumark ancanegativepauciimmuneglomerulonephritiswithsystemicinvolvement
AT ramakrishnanm ancanegativepauciimmuneglomerulonephritiswithsystemicinvolvement
AT sahak ancanegativepauciimmuneglomerulonephritiswithsystemicinvolvement
AT gowthams ancanegativepauciimmuneglomerulonephritiswithsystemicinvolvement
AT ajeshkumarrn ancanegativepauciimmuneglomerulonephritiswithsystemicinvolvement